Abstract:Mitochondrial network is constantly in a dynamic and regulated balance of fusion and fission processes, which is known as mitochondrial dynamics. Mitochondria make physical contacts with almost every other membrane in the cell thus impacting cellular functions. Mutations in mitochondrial dynamics genes are known to cause neurogenetic diseases. To better understand the consequences on the cellular phenotype and pathophysiology of neurogenetic diseases associated with defective mitochondrial dynamics, we have compared the fibroblasts phenotypes of (i) patients carrying pathogenic variants in genes involved in mitochondrial dynamics such as DRP1 (also known as DNM1L ), GDAP1 , OPA1 , and MFN2 , and (ii) patients carrying mutated genes that their dysfunction affects mitochondria or induces a mitochondrial phenotype, but that are not directly involved in mitochondrial dynamic network, such as FXN (encoding frataxin, located in the mitochondrial matrix), MED13 (hyperfission phenotype), and CHKB (enlarged mitochondria phenotype). We identified mitochondrial network alterations in all patients’ fibroblasts except for CHKB Q198*/Q198* . Functionally, all fibroblasts showed mitochondrial oxidative stress, without membrane potential abnormalities. The lysosomal area and distribution were abnormal in GDAP1 W67L/W67L , DRP1 K75E/+ , OPA1 F570L/+ , and FXN R165C/GAA fibroblasts. These lysosomal alterations correlated with mitochondria-lysosome membrane contact sites (MCSs) defects in GDAP1 W67L/W67L exclusively. The study of mitochondrial contacts in all samples further revealed a significant decrease in MFN2 R104W/+ fibroblasts. GDAP1 and MFN2 are outer mitochondrial membrane (OMM) proteins and both are related to Charcot-Marie Tooth neuropathy. Here we identified their constitutive interaction as well as MFN2 interaction with LAMP-1. Therefore MFN2 is a new mitochondria-lysosome MCSs protein. Interestingly, GDAP1 W67L/W67L and MFN2 R104W/+ fibroblasts carry pathogenic changes that occur in their catalytic domains thus suggesting a functional role of GDAP1 and MFN2 in mitochondria–lysosome MCSs. Finally, we observed starvation-induced autophagy alterations in DRP1 K75E/+ , GDAP1 W67L/W67L , OPA1 F570L/+ , MFN2 R104W/+ , and CHKB Q198*/Q198* fibroblasts. These genes are related to mitochondrial membrane structure or lipid composition, which would associate the OMM with starvation-induced autophagy. In conclusion, the study of mitochondrial dynamics and mitochondria-lysosome axis in a group of patients with different neurogenetic diseases has deciphered common and unique cellular phenotypes of degrading and non-degrading pathways that shed light on pathophysiological events, new biomarkers and pharmacological targets for these disorders.

Cellular pathophysiological consequences of BCS1L mutations in mitochondrial complex III enzyme deficiency

Impact of the mitochondrial genetic background in complex III deficiency

A Novel Mutation In The Ubiquinol-Cytochrome C Reductase Synthesis-Like Gene Associated With Complex Iii Deficiency And Bjornstad Syndrome A Case Report

Pathogenesis of mtDNA point mutation m.10191T>C affecting complex I function is a multifactorial process leading to metabolic remodeling of mitochondria

Biallelic variants in result in reduced assembly of the mitoribosomal small subunit with altered intrinsic and extrinsic apoptosis and a Perrault syndrome-spectrum phenotype

Linking the Landscape of MYH9-Related Diseases to the Molecular Mechanisms that Control Non-Muscle Myosin II-A Function in Cells

Long‐term hematopoietic dysfunction in patients with large‐scale mitochondrial DNA deletion syndromes

Mitochondrial Dynamics and Mitochondria-Lysosome Contacts in Neurogenetic Diseases

Loss-of-function mutations in MICU 1 cause a brain and muscle disorder linked to primary alterations in mitochondrial Ca 2 + signalling

Clinical and molecular findings in children with complex I deficiency

Excessive BNIP3-and BNIP3L-dependent Mitophagy Underlies the Pathogenesis of FBXL4-mutated Mitochondrial DNA Depletion Syndrome

Mitochondrial cytochrome c oxidase deficiency.

Novel COX11 Mutations Associated with Mitochondrial Disorder: Functional Characterization in Patient Fibroblasts and Saccharomyces cerevisiae

Leigh syndrome is the main clinical characteristic of PTCD3 deficiency

Depletion of BBSome Subunits Alters Receptor Endocytosis and Promotes EMT via TGF-β Signaling

Alterations in oxidative phosphorylation complexes in arrhythmogenic cardiomyopathy using desmosomal KO cell model

Biophysical Investigation of the MMDS3 Causing Gly104Cys Variant of IBA57

Defective NADPH production in mitochondrial disease complex I causes inflammation and cell death

Mutations of the mitochondrial genome: clinical overview and possible pathophysiology of cell damage

Mitochondrial DNA depletion syndrome: new descriptions and the use of citrate synthase as a helpful tool to better characterise the patients

[Mitochondrial Respiratory Chain Complex I Deficiency Due to 10191T>C Mutation in ND3 Gene].